Cargando…

SDHB Suppresses the Tumorigenesis and Development of ccRCC by Inhibiting Glycolysis

Metabolic reprogramming is the prominent feature of clear cell renal cell carcinoma (ccRCC). Succinate dehydrogenase subunit B (SDHB) is one of subunits of mitochondrial respiratory chain complex II. The loss of SDHB function is closely related with metabolic changes in kidney cancer cells. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Zhiyu, Sun, Qiang, Yang, Huihui, Zheng, Junfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170479/ https://www.ncbi.nlm.nih.gov/pubmed/34094922 http://dx.doi.org/10.3389/fonc.2021.639408

Ejemplares similares

Cuproptosis in ccRCC: key player in therapeutic and prognostic targets
por: Lv, Yang, et al.
Publicado: (2023)

Untangling ccRCC prognosis with SLINKY
por: Reinfeld, Bradley I., et al.
Publicado: (2017)

CD146 as a Prognostic-Related Biomarker in ccRCC Correlating With Immune Infiltrates
por: Lv, Zheng, et al.
Publicado: (2021)

Integrative Analysis of DNA Methylation Identified 12 Signature Genes Specific to Metastatic ccRCC
por: Qian, Siwei, et al.
Publicado: (2020)

Functional and translational consequences of immunometabolic coevolution in ccRCC
por: Reznik, Ed, et al.
Publicado: (2023)

MT1X is an oncogene and indicates prognosis in ccRCC
por: Ding, Yanpeng, et al.
Publicado: (2022)

CD44 Is Associated with Poor Prognosis of ccRCC and Facilitates ccRCC Cell Migration and Invasion through HAS1/MMP9
por: Du, Tan, et al.
Publicado: (2023)

PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability
por: Chen, Siming, et al.
Publicado: (2021)

Pivotal biomarker expression and drug screening in advanced ccRCC
por: Xiao, Wen, et al.
Publicado: (2020)

Identification of key genes of the ccRCC subtype with poor prognosis
por: Puzanov, Grigory Andreevich
Publicado: (2022)

Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC
por: Ribback, Silvia, et al.
Publicado: (2021)

The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC
por: Qi, Xiaochen, et al.
Publicado: (2021)

Does the Urinary Proteome Reflect ccRCC Stage and Grade Progression?
por: Santorelli, Lucia, et al.
Publicado: (2021)

A multiomics disease progression signature of low-risk ccRCC
por: Strauss, Philipp, et al.
Publicado: (2022)

Knockdown of SETD2 promotes erastin-induced ferroptosis in ccRCC
por: Xue, Wei, et al.
Publicado: (2023)

Increased expression of the RNA-binding protein Musashi-2 is associated with immune infiltration and predicts better outcomes in ccRCC patients
por: Li, Hui, et al.
Publicado: (2022)

The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth
por: Li, Xu, et al.
Publicado: (2022)

Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database
por: Wan, Bangbei, et al.
Publicado: (2020)

Bioinformatics Analysis of Prognostic Value of SPC24 in ccRCC and Pan-Cancer
por: Zhang, Jipeng, et al.
Publicado: (2022)

Identification of FDFT1 as a potential biomarker associated with ferroptosis in ccRCC
por: Huang, Ruizhen, et al.
Publicado: (2022)

Identification of AKI signatures and classification patterns in ccRCC based on machine learning
por: Wang, Li, et al.
Publicado: (2023)

Clinical Benefit of Niraparib to TKI/mTORi-Resistance Metastatic ccRCC With BAP1-Frame Shift Mutation: Case Report and Literature Review
por: Lian, Bi-Jun, et al.
Publicado: (2022)

Novel Diagnostic Value of Driver Gene Transcription Signatures to Characterise Clear Cell Renal Cell Carcinoma, ccRCC
por: Ujfaludi, Zsuzsanna, et al.
Publicado: (2022)

Integrated Multi-Omics Analysis Identified PTPRG and CHL1 as Key Regulators of Immunophenotypes in Clear Cell Renal Cell Carcinoma(ccRCC)
por: Zeng, Xing, et al.
Publicado: (2022)

Overexpression CPT1A reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC: CPT1A inhibits ccRCC cell proliferation via PPARα/CD36 axis
por: Yang, Hui, et al.
Publicado: (2021)

GLUD1 suppresses renal tumorigenesis and development via inhibiting PI3K/Akt/mTOR pathway
por: Wang, Lei, et al.
Publicado: (2022)

Expression of micro-RNAs and genes related to angiogenesis in ccRCC and associations with tumor characteristics
por: Oliveira, Rita de Cássia, et al.
Publicado: (2017)

Transcription Factor and miRNA Interplays Can Manifest the Survival of ccRCC Patients
por: Qin, Shijie, et al.
Publicado: (2019)

In-Depth Mapping of the Urinary N-Glycoproteome: Distinct Signatures of ccRCC-related Progression
por: Santorelli, Lucia, et al.
Publicado: (2020)

LRG1 May Accelerate the Progression of ccRCC via the TGF-β Pathway
por: Hong, Quan, et al.
Publicado: (2020)

SCD5 Regulation by VHL Affects Cell Proliferation and Lipid Homeostasis in ccRCC
por: Ganner, Athina, et al.
Publicado: (2023)

ACAT1 and Metabolism-Related Pathways Are Essential for the Progression of Clear Cell Renal Cell Carcinoma (ccRCC), as Determined by Co-expression Network Analysis
por: Chen, Liang, et al.
Publicado: (2019)

Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors
por: Wrzesiński, Tomasz, et al.
Publicado: (2015)

HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism
por: Du, Weinan, et al.
Publicado: (2017)

Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
por: Reustle, Anna, et al.
Publicado: (2020)

Transcriptional Profiling Reveals Kidney Neutrophil Heterogeneity in Both Healthy People and ccRCC Patients
por: Meng, Yiliang, et al.
Publicado: (2021)

Establishment of a ccRCC patient-derived chick chorioallantoic membrane model for drug testing
por: Charbonneau, Martine, et al.
Publicado: (2022)

Identification and validation of SERPINE1 as a prognostic and immunological biomarker in pan-cancer and in ccRCC
por: Li, Lingqin, et al.
Publicado: (2023)

The immune‐related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation
por: Chen, Siming, et al.
Publicado: (2021)

A Comprehensive Study of Progressive Cytogenetic Alterations in Clear Cell Renal Cell Carcinoma and a New Model for ccRCC Tumorigenesis and Progression
por: Zhang, Zhongfa, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_mhn48cgd4hf58urh9vr0gcookt